In vitro CTL precursor frequencies do not reflect a beneficial effect of cross-reactive group (CREG) matching

被引:5
作者
Stobbe, I
van der Meer-Prins, EMW
de Lange, P
Oudshoorn, M
Doxiadis, IIN
Claas, FHJ
机构
[1] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2300 RC Leiden, Netherlands
[2] Europdonor Fdn, Leiden, Netherlands
关键词
CTLpf; CREG matching; transplantation; HLA matching;
D O I
10.1016/S0198-8859(00)00160-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Adjustment of histocompatibility-based allocation criteria in kidney transplantation from HLA matching to matching on the basis of cross-reactive groups (CREG), was recently suggested to be a good alternative to transplant with more "well-matched" kidneys, without negatively influencing graft survival. Because graft rejection is often mediated by cytotoxic T cells (CTLs), we investigated whether a beneficial effect of CREG matching is reflected in vitro by lower CTL precursor frequencies (CTLpf). Therefore, CTLpf were determined in a group of healthy individuals and analyzed with respect to the number of HLA and CREG mismatches. A clear correlation was found between the number of HLA mismatches and the CTLpf, that is, the lowest mean frequency in case of 0 HLA-A, B mismatches (66 CTL precursors per 10(6) cells) and che highest in combinations with 4 HLA mismatches (mean 303 CTLp/10(6) cells). The situation was different in the case of CREG mis-marches. Although the highest frequency was found in the group of 4 CREG mismatches, no significant differences were observed between 0, 1, and 2 CREG mismatches. High CTLpf, up to 430/10(6), were even seen in the case of 0 CREG mismatches. Also within a well-defined group of single HLA-A or HLA-B mismatches no difference in CTLpf were observed between the subgroups with 0 vs. 1 CREG mismatches. The present study showed chat in vitro the CTLpf correlates better with HLA than with CREG matching. These data are consistent with findings reported by several groups chat matching for the CREG does not benefit transplant outcome. Human Immunology 61: 879-883 (2000). (C) American Society for Histocompatibility and Immunogenetics, 2000. Published by Elsevier Science Inc.
引用
收藏
页码:879 / 883
页数:5
相关论文
共 24 条
[1]   DETERMINATION OF CYTOTOXIC LYMPHOCYTE-T PRECURSOR FREQUENCIES USING EUROPIUM LABELING AS A NONRADIOACTIVE ALTERNATIVE TO LABELING WITH CHROMIUM-51 [J].
BOUMA, GJ ;
VANDERMEERPRINS, PMW ;
VANBREE, FPMJ ;
VANROOD, JJ ;
CLAAS, FHJ .
HUMAN IMMUNOLOGY, 1992, 35 (02) :85-92
[2]   THE IMPACT OF HLA MISMATCHES ON THE SURVIVAL OF FIRST CADAVERIC KIDNEY-TRANSPLANTS [J].
HELD, PJ ;
KAHAN, BD ;
HUNSICKER, LG ;
LISKA, D ;
WOLFE, RA ;
PORT, FK ;
GAYLIN, DS ;
GARCIA, JR ;
AGODOA, LYC ;
KRAKAUER, H .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (12) :765-770
[3]   INFLUENCE OF HLA MATCHING ON REJECTIONS AND SHORT-TERM AND LONG-TERM PRIMARY CADAVERIC ALLOGRAFT SURVIVAL [J].
KERMAN, RH ;
KIMBALL, PM ;
LINDHOLM, A ;
VANBUREN, CT ;
KATZ, SM ;
LEWIS, RM ;
MCCLAIN, J ;
PODBIELSKI, J ;
WILLIAMS, J ;
KAHAN, BD .
TRANSPLANTATION, 1993, 56 (05) :1242-1247
[4]   KIDNEY-TRANSPLANTS IN BLACK RECIPIENTS - HLA MATCHING AND OTHER FACTORS AFFECTING LONG-TERM GRAFT-SURVIVAL [J].
KOYAMA, H ;
CECKA, JM ;
TERASAKI, PI .
TRANSPLANTATION, 1994, 57 (07) :1064-1068
[5]   THE PUBLIC DETERMINANTS HLA-BW4/BW6 DO NOT GENERATE CYTO-TOXIC LYMPHOCYTE-T (CTLS) [J].
LOPEZLARREA, C ;
ARNAIZVILLENA, A .
CELLULAR IMMUNOLOGY, 1989, 123 (02) :441-444
[6]   Matching for private or public HLA epitopes reduces acute rejection episodes and improves two-year renal allograft function [J].
McKenna, RM ;
Lee, KR ;
Gough, JC ;
Jeffery, JR ;
Grimm, PC ;
Rush, DN ;
Nickerson, P .
TRANSPLANTATION, 1998, 66 (01) :38-43
[7]  
MILFORD EL, 1987, TRANSPLANT P, V19, P30
[8]  
OPELZ G, 1989, TRANSPLANT P, V21, P3881
[9]  
OPELZ G, 1992, CLIN INVESTIGATOR, V70, P767
[10]   THE DETECTION OF CYTOTOXIC T-CELLS WITH HIGH-AFFINITY RECEPTORS FOR DONOR ANTIGENS IN THE TRANSPLANTED HEART AS A PROGNOSTIC FACTOR FOR GRAFT-REJECTION [J].
OUWEHAND, AJ ;
BAAN, CC ;
ROELEN, DL ;
VAESSEN, LMB ;
BALK, AHMM ;
JUTTE, NHPM ;
BOS, E ;
CLAAS, FHJ ;
WEIMAR, W .
TRANSPLANTATION, 1993, 56 (05) :1223-1229